Saw the message that there is no winners circle trip because of COVID. So GSK thinks it’s not safe enough to go on a trip but is pushing us to go out and make calls in offices?
I am more pissed that several winners have a decile 10 performance, this going into offices bullshit has been going on since last may, over that crap too!!
spot on this is the most two faced backwards logic. Just another way to show no appreciation to their teams. Yet it is perfectly safe to go back into hospitals, clinics and health departments. Who is stupid enough to fall for this?
Achieving quota is not important at GSK. Winners crowned for poor sales numbers, yet high GSO ratings. That is counterintuitive logic and agree GSK has lost its way. This is a top down culture issue. Look at GSK stock versus our competitors. High sales performers leave for the competitor while others who have learned to play the game stay.
only a rep here, but I've learned that this is no place to make money from performance - what's important is to manage up with the appearance of activity. it helps if you document at least 2 levels up how valuable your leadership chain is and how much they help you, "serve patient needs". regardless of what you sell, this will garner you higher rating at year end, more earning and a more upwardly mobile career path. the only fun I really have its fucking with fleet. those dweebs are the worst. they think they know what I am up to, but I've got them fooled. so long as they guys I loan my car to do get any tickets or preventable accidents, my two timing gig is making me bank. covid has really created an opportunity with the company car
I agree 100% with your post. I have been at GSK about 2 years and started looking 6 months after I was hired realizing very quickly that this is not a place for high performing reps. GSK is a place for primary care reps to settle and make ok money by giving GSK what they want by hitting KPI and sample drop percentages. This KPI is the stupidest bullshit I have ever seen, half my team hits 100% of their KPI but never reaches territory sales goal, go figure?
Since it’s not safe to go on a winners circle trip it’s definitely not save to go into offices. So I’ll refrain from making any live calls for the foreseeable future.
Covid has exposed what everyone already knew, pharma sales is a dead model. The new way of interacting with docs is virtual with the occasional ftf interaction meaning pharma companies needs about a third of their current sales force. This will start to unfold at the end of this year and 2022 will be a full blown blood bath of layoffs and sales force reductions. The Biden economic policies will also help expedite this as well.